Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: An 85-case French multicentric report

American Journal of Transplantation

Volumn 8, Issue 6, 2008, Pages 1205-1213

  Le Treut, Y P ^a   Gregoire E ^a   Belghiti, J ^b   Boillot, O ^c   Soubrane, O ^d   Mantion, G ^e   Cherqui, D ^f   Castaing, D ^g   Ruszniewski, P ^b   Wolf, P ^h   Paye, F ⁱ   Salame, E ^j   Muscari, F ^k   Pruvot, F R ^l   Baulieux, J ^m  

^a HÔPITAL DE LA CONCEPTION   (France)

^b BEAUJON HOSPITAL   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d Hôpital Cochin ^*  (France)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f HENRI MONDOR HOSPITAL   (France)

^g HÔPITAL PAUL BROUSSE   (France)

^h HÔPITAL DE HAUTEPIERRE   (France)

ⁱ HÔPITAL SAINT ANTOINE   (France)

^j CHU CÔTE DE NACRE   (France)

^k CHU RANGUEIL   (France)

^l LILLE UNIVERSITY HOSPITAL   (France)

^m CROIX ROUSSE HOSPITAL   (France)

more..

Author keywords

Metastasis; Multivariate analysis; Patient survival rate; Prognostic factors; Transplant registry; Transplantation outcomes; Tumor

Indexed keywords

ADULT; ARTICLE; DUODENUM TUMOR; ENDOCRINE TUMOR; EVISCERATION; FEMALE; GRAFT SURVIVAL; HEPATOMEGALY; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORTALITY; PANCREAS TUMOR; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; TRACHEOBRONCHIAL TREE; TREATMENT INDICATION; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; ENDOCRINE GLAND NEOPLASMS; FEMALE; FRANCE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 44449159393     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02233.x     Document Type: Article

References (33)

1. Chamberlain RS, Canes D, Brown KT et al. Hepatic neuroendocrine metastases: Does intervention alter outcomes J Am Coll Surg 2000 190 : 432 445.
2. Jensen RT. Natural history of digestive endocrine tumors. In : Mignon M, Colombel JF, eds. Recent advances in pathophysiology and management of inflammatory bowel disease and digestive endocrine tumors. Paris : John Libbey Eurotext Publishing, 1999 : 192 219.
3. Moertel CG. An Odyssey in the land of small tumor. J Clin Oncol 1987 5 : 1503 1522.
4. Pape UF, Böhming M, Berndt U, Tiling N, Wiedenmann B, Plöckinger U. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a German referral center. Ann NY Acad Sci 2004 1014 : 222 233.
5. Sutcliffe R, Maguire D, Ramage JK, Rela M, Heaton N. Management of neuroendocrine liver metastases. Am J Surg 2004 187 : 39 46.
6. Touzios JG, Kiely JM, Pitt SC et al. Neuroendocrine hepatic metastases. Does aggressive management improve survival Ann Surg 2005 241 : 776 785.
7. Consensus Conference. Indications for liver transplantation. January 19 and 20, 2005, Lyon-Palais des congrès. Liver Transplant 2006 12 : 998 1011.
8. Punch J, Gish RA. MELD exception for uncommun hepatic tumors. Liver Transplant 2006 12 : S122 S123.
9. ELTR. Update of December 2005. Available from : http://eltr.org.
10. O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl 2000 6 : S23 S29.
11. Le Treut YP, Delpero JR, Dousset B et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case french multicentric report. Ann Surg 1997 225 : 355 364.
12. Coppa J, Pulvirenti A, Schiavo M. Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc 2001 33 : 1537 1539.
13. Lang H, Oldhafer KJ, Weimann A et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997 223 : 347 354.
14. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma. Transplantation 1998 66 : 1307 1312.
15. Pascher A, Klupp J, Neuhaus P. Transplantation in the management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol 2005 19 : 637 648.
16. Rosenau J, Bahr M, Von Wasielewski R et al. Ki67, E-cadherin and p53 as prognostic indicators of long term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 2002 73 : 386 394.
17. Florman S, Toure B, Kim L et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg 2004 8 : 208 212.
18. Frilling A, Malago M, Weber F et al. Liver transplantation for patients with metastatic endocrine tumors: Single-center experience with 15 patients. Liver Transplant 2006 12 : 1089 1096.
19. Olausson M, Friman S, Cahlin C et al. Indications and results of liver transplantation in patients with neuroendocrine tumors. World J Surg 2002 26 : 998 1004.
20. Olausson M, Friman S, Herlenius G et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transplant 2007 13 : 327 333.
21. van Vilsteren FGI, Baskin-Bey ES, Nagorney DM et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival. Liver Transplant 2006 12 : 448 456.
22. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: How to select patients for liver transplantation J Hepatol 2007 47 : 460 466.
23. Heinemann A, Wischhusen F, Püschel K, Rogiers X. Standard liver volume in the caucasian population. Liver Transplant Surg 1999 5 : 366 368.
24. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004 1014 : 13 27.
25. Norton JA, Fraker DL, Alexander HR, Gibril F, Liewehr DJ, Venzon DJ. Surgery increases survival in patients with gastrinoma. Ann Surg 2006 244 : 410 420.
26. Starzl TE, Todo S, Tzakis A. et al. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989 210 : 374 385.
27. Johanson V, Tisell LE, Olbe L, Wänberg B, Nilsson O, Ahlman H. Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin. Br J Cancer 1999 80 : 1259 1261.
28. Fenwick SW, Wyatt JI, Toogood GJ, Lodge JPA. Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg 2004 239 : 210 219.
29. Maire F, Couvelard A, Vullierme MP et al. Primary endocrine tumours of the liver. Br J Surg 2005 92 : 1255 1260.
30. Modlin IM, Shapiro MD, Kidd M. An analysis of rare carcinoid tumors: Clarifying these clinical conundrums. World J Surg 2005 29 : 92 101.
31. Blonski WC, Reddy KR, Shaked A, Siegelman E, Metz DC. Liver transplantation for metastatic neuroendocrine tumor: A case report and review of the literature. World J Gastroenterol 2005 11 : 7676 7683.
32. Vauthey JN, Abdalla EK, Doherty DA et al. Body surface area and body weight predict total liver volume in western adults. Liver Transplant 2002 8 : 233 240.
33. Rosado B, Gores G. Liver transplantation for neuroendocrine tumors: Progress and uncertainty. Liver Transpl 2004 10 : 712 713.